Author

C. Ciancia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:proteomics· 1

Frequent Co-Authors

R. M. Maizels· 2 shared A. Giordano· 1 shared A. Mukundan· 1 shared A. P. Hinck· 1 shared A. Sanders· 1 shared A. Turtoi· 1 shared C. Britton· 1 shared C. Josephine· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

R. M. Maizels

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tuft cell-derived acetylcholine is an effector of type 2 immunity and directly targets helminth parasites in the gut lumen

M. Ndjim, F. Herbert, I. Gasmi, C. Josephine, S. Henry, E. Turtoi, S. Thirard, A. Giordano, C. Ciancia, C. Britton, E. Devaney, T. N. McNeilly, S. Berrard, A. Turtoi, R. M. Maizels, , P. Jay

The paper shows tuft cells release acetylcholine to directly target helminth parasites in the gut, enhancing type 2 immunity.

bioRxiv · Dec 8, 2023 · PreprintImmunology

The helminth TGF-beta mimic TGM4 is a modular ligand that binds CD44, CD49d and TGF-beta receptors to preferentially target myeloid cells

S. Singh, D. J. Smyth, K. Cunningham, A. Mukundan, C.-H. Byron, C. S. Hinck, M. P. J. White, C. Ciancia, N. Wosowska, A. Sanders, R. Jin, S. Lilla, S. Zanivan, C. Schoenherr, G. Inman, , R. M. Maizels

This paper identifies TGM4, a helminth TGF-beta mimic, as a modular ligand that selectively targets myeloid cells through specific receptor interactions, differing from TGM1's broader T cell targeting.

bioRxiv · Nov 13, 2023 · PreprintImmunology